# XLV holdings: all 62 positions

> All 62 XLV holdings with weights, as of Oct 13, 2026. The top 3 are LLY 15.15%, JNJ 9.73% and ABBV 7.87%. Download the full list as a CSV.

Data as of Oct 13, 2026. Rebuilt every trading night.

XLV held 62 positions as of Oct 13, 2026. Eli Lilly & Co is the largest at 15.15%; the top 10 are 60.0% of the fund.

Source: State Street (https://www.ssga.com/us/en/intermediary/library-content/products/fund-data/etfs/us/holdings-daily-us-en-xlv.xlsx).

| # | Holding | Ticker | Weight |
| --- | --- | --- | --- |
| 1 | Eli Lilly & Co | LLY | 15.15% |
| 2 | Johnson & Johnson | JNJ | 9.73% |
| 3 | AbbVie Inc | ABBV | 7.87% |
| 4 | Merck & Co Inc | MRK | 5.69% |
| 5 | UnitedHealth Group Inc | UNH | 5.50% |
| 6 | Thermo Fisher Scientific Inc | TMO | 3.98% |
| 7 | Amgen Inc | AMGN | 3.62% |
| 8 | Gilead Sciences Inc | GILD | 2.98% |
| 9 | Abbott Laboratories | ABT | 2.88% |
| 10 | Pfizer Inc | PFE | 2.62% |
| 11 | Intuitive Surgical Inc | ISRG | 2.42% |
| 12 | Danaher Corp | DHR | 2.26% |
| 13 | Vertex Pharmaceuticals Inc | VRTX | 2.00% |
| 14 | Bristol-Myers Squibb Co | BMY | 1.88% |
| 15 | Medtronic PLC | MDT | 1.85% |
| 16 | McKesson Corp | MCK | 1.82% |
| 17 | CVS Health Corp | CVS | 1.82% |
| 18 | Stryker Corp | SYK | 1.60% |
| 19 | Elevance Health Inc | ELV | 1.50% |
| 20 | Moderna Inc | MRNA | 1.30% |
| 21 | Cigna Group/The | CI | 1.21% |
| 22 | Regeneron Pharmaceuticals Inc | REGN | 1.20% |
| 23 | HCA Healthcare Inc | HCA | 1.10% |
| 24 | Cencora Inc | COR | 1.02% |
| 25 | Boston Scientific Corp | BSX | 1.02% |
| | SSI US Gov Money Market Class | | 0.23% |
| | US Dollar | | −0.07% |
| | Cash and other net assets | | 0.04% |

The largest 25 of 62 positions are shown. All of them: https://etfiq.com/funds/xlv/holdings/xlv-holdings.csv (CSV) or https://etfiq.com/data/books/xlv.json (JSON).

Fund page: https://etfiq.com/funds/xlv

Cite: ETFIQ, Holdings of XLV, data as of Oct 13, 2026. https://etfiq.com/funds/xlv/holdings/